CABG shows survival benefits in study of patients with diabetes, CAD

08/13/2013 | Healio

Data on 232 patients with diabetes and multivessel coronary artery disease indicated that those who underwent coronary artery bypass graft surgery had lower rates of cardiac and overall mortality at 10 years, compared with those who received medical therapy. Differences in mortality rates between percutaneous coronary intervention and both medical therapy and CABG were not statistically significant, researchers reported in the American Heart Journal.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA